indirubin (Compound)

Synonyms:Indirubin, 479-41-4, Indigo Red, Couroupitine B, Indigopurpurin, 906748-38-7, (Z)-[2,3'-biindolinylidene]-2',3-dione, [2,3'-Biindolinylidene]-2',3-dione, 397242-72-7, Isoindirubin, Isoindirubine, Isoindogotin, (E)-[2,3'-biindolinylidene]-2',3-dione, Indirubin [MI], NSC 105327, NSC-105327, 2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-, C.I. 73200, Indirubin 3E-form [MI], 3-(3-oxo-1H-indol-2-ylidene)-1H-indol-2-one, 1LXW6D3W2Z, V86L8P74GI, 2-(2-hydroxy-1H-indol-3-yl)indol-3-one, C.I. 75790, 3-(1,3-dihydro-3-oxo-2h-indol-2-ylidene)-1,3-dihydro-2h-indol-2-one, MFCD00956441, (Z)-[2,3 inverted exclamation mark -Biindolinylidene]-2 inverted exclamation mark ,3-dione, (3Z)-3-(1,3-Dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-2H-indol-2-one, MFCD00221745, (3E)-3-(1,3-Dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-2H-indol-2-one, 3-(1,3-dihydro-3-oxo-2h-indol-2-ylidene)-1,3-dihydro-2h-indol-2-on, 2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-, (3E)-, SMR000466311, BRN 0088279, UNII-V86L8P74GI, Indirubin,(S), Indirubin- Bio-X, INDARUBICIN, (delta2,3'-Biindoline)-2',3-dione, CPD000466311, Indirubin derivative, 1, BiomolKI_000069, EM-A05-INDIRUBIN, [.DELTA.2,3-dione, BiomolKI2_000073, UNII-1LXW6D3W2Z, INDIRUBIN [WHO-DD], (3Z)-3-(3-oxoindolin-2-ylidene)indolin-2-one, (delta(sup 2,3')-BIINDOLINE)-2',3-DIONE, SCHEMBL27678, BMK1-G9, BSPBio_001110, KBioGR_000450, KBioSS_000450, 5-24-08-00507 (Beilstein Handbook Reference), MLS000759416, MLS001424211, MLS002473308, MLS006010732, CHEMBL35349, BDBM7392, CHEMBL259664, SCHEMBL9899338, (3E)-3-(3-oxo-1H-indol-2-ylidene)-1H-indol-2-one, CHEMBL1276127, CHEMBL3185783, CHEBI:92322, cid_5318433, KBio2_000450, KBio2_003018, KBio2_005586, KBio3_000839, KBio3_000840, EX-A347, Bio2_000395, Bio2_000875, DTXSID201026053, DTXSID501026052, HMS1362H11, HMS1792H11, HMS1990H11, HMS2051H20, HMS2234G06, HMS3369O15, HMS3393H20, HMS3403H11, HMS3656O13, ACT03264, AMY39890, BCP28869, HY-N0117, AC1180, BDBM50023867, BDBM50349806, FD9058, NSC105327, s2386, 2H-Indol-2-one,3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-, AKOS015895136, AKOS028108775, AKOS032455876, AC-8003, BCP9000788, CCG-100673, CCG-101058, CCG-267073, CS-3682, DB12379, NC00308, SB64698, IDI1_002150, (2'Z)-Indirubin, >=98% (HPLC), NCGC00163356-01, NCGC00163356-02, NCGC00163356-03, NCGC00163356-04, NCGC00179302-02, (Z)-[2,3-Biindolinylidene]-2,3-dione, AC-29931, BI164578, CS-12423, LS-14462, SMR004701694, SY058396, 3-(3-oxoindolin-2-ylidene)indolin-2-one, 3-(3-indolinone-2-ylidene)-indolin-2-one, UNM-0000305766, FT-0627199, I0868, SW197688-2, (E)-[2,3-BIINDOLINYLIDENE]-2,3-DIONE, AB00639939-06, 2-(2-oxo-1H-indol-3-ylidene)-1H-indol-3-one, A827403, A922429, SR-01000759396, Q-100514, Q1661452, SR-01000759396-5, BRD-K17894950-001-03-6, BRD-K17894950-001-04-4, C.I.73200;Couroupitine B;Indigo red;Indigopurpurin, Q27164070, 3-(3-oxidanylidene-1H-indol-2-ylidene)-1H-indol-2-one, 2H-Indol-2-one,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-, (3E)-3-(3-Oxo-1,3-dihydro-2H-indol-2-ylidene)-1,3-dihydro-2H-indo l-2-one, (Z)-[2,3invertedexclamationmark-Biindolinylidene]-2invertedexclamationmark,3-dione, 2-[(3Z)-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-2,3-dihydro-1H-indol-3-one
Pubchem:PUBCHEM:5318433
Id:a817b1e4-32c7-556c-9eb4-286b40acd9af
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View indirubin's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for indirubin.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with indirubin.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.